HFCWO in Children With Non-CF Bronchiectasis
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: High Frequency Chest Wall Oscillation, conventional physiotherapy program directed towards improvement of pulmonary functions and quality of life..
- Who it may be relevant to
- Registry conditions: Non Cystic Fibrosis Bronchiectasis. Basic parameters: 6 years — 12 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Egypt
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Effect of High Frequency Chest Wall Oscillation on Pulmonary Functions in Children With Non-Cystic Fibrosis Bronchiectasis
Overview
the study will concentrate on the effect of High Frequency Chest Wall Oscillation compared to conventional pulmonary physiotherapy on children with non cystic fibrosis bronchiectasis
Detailed description
The purpose of this study is to evaluate the effect of using HFCWO intervention on pulmonary functions in children with bronchiectasis.
it hypothesized that Using HFCWO has no effect on pulmonary functions and hospital stay in children with bronchiectasis.
Children subjected to the inclusion criteria will be assigned randomly into two groups, control group and study group.
Does high frequency chest wall oscillation (HFCWO) have an effect in pulmonary functions in children with bronchiectasis? RCT study Control group Patients in this group will be 30 children who will be treated by conventional physiotherapy program directed towards improvement of pulmonary functions and quality of life.
Study group This group will include 30 children who will use HFCWO for 20 minutes, in addition to 10 minutes of the same conventional program of physiotherapy given to the control group.
The frequency of treatment will be 5 sessions/week for three successive months for both groups for long term effect and daily for immediate effect.
outcome measure: FEV1, FVC, FEV1/FVC quality of life for bronchiectasis, 6-minute walk test
Interventions
- Device High Frequency Chest Wall Oscillation
High-frequency chest wall oscillation that applies external chest wall oscillations via an inflatable vest worn around the thoracic cage, increasing the air-liquid shear forces during expiration is believed to result in secretion mobilization. The product name that will be used is Air Way Clearness system; his model is PV-900/ PV-300/PV-100, made in China. - Other conventional physiotherapy program directed towards improvement of pulmonary functions and quality of life.
conventional physiotherapy program directed towards improvement of pulmonary functions and quality of life. Conventional physiotherapy that will be applied to the control group for 30 minutes will include: * Postural drainage according to accumulation of secretions for 10 minutes accompanied by percussion or vibration * Active cycle breathing technique (ACBT) for 10 minutes * Respiratory exercises for 10 minutes
Primary outcome measures
- Forced Expiratory Volume in 1 second (FEV1) [Time frame: Baseline and after 8 weeks of treatment]
- Forced Vital Capacity (FVC) [Time frame: Baseline and after 6 months of treatment]
- FEV1/FVC Ratio [Time frame: Baseline and after 6 months of treatment]
Secondary outcome measures (1)
- Six-Minute Walk Distance (6MWD) [Time frame: Baseline and after 6 months of treatment]
Eligibility criteria
Inclusion criteria
- • Children with no cystic fibrosis bronchiectasis
- Both sexes
- Their ages ranges from 6-12 years
- After 48 hours of attack, if hemoptysis or fever not found
Exclusion criteria
- • Osteoporosis (Calcium deficiency)
- Bleeding tendency
- Recent surgery of brain, eye, thoracic, or neck surgery
- Pneumothorax
- Cystic fibrosis bronchiectasis
- Pulmonary embolism
- Rib fracture
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Triple blind
- Primary purpose
- Treatment
Study locations
Egypt · 1 center
- pediatric hospital, Assiut university — Asyut
Identifiers
NCT: NCT07722364 · HFCWO and bronchectasis